Nymalize 6 mg/mL Oral Solution
RxNorm 2361313
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2361313 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Nymalize 6 mg/mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Nimodipine 6 mg/ML Oral Solution [Nymalize]
(Atom ID: 12387985)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
NiMODipine 6 mg/ML Oral Solution [Nymalize]
(Atom ID: 12388000)
SYPrescribable
Synonym (SY):
Nymalize 30 mg per 5 mL Oral Solution
(Atom ID: 12387989)
PSNPrescribable
Prescribable Name (PSN):
Nymalize 6 mg/mL Oral Solution
(Atom ID: 12759563)
SYPrescribable
Synonym (SY):
Nymalize 6 mg/ML Oral Solution
(Atom ID: 12387986)
SYPrescribable
Synonym (SY):
Nymalize 60 mg per 10 mL Oral Solution
(Atom ID: 12387994)
Patient Education
Nimodipine
Nimodipine is used to decrease brain damage that may be caused by a subarachnoid hemorrhage (bleeding in the space surrounding the brain that occurs when a weakened blood vessel in the brain bursts). Nimodipine is in a class of medications called calcium channel blockers. It works by relaxing blood vessels in the brain to allow more blood to flow to damaged areas.
[Learn More]
* Please review the disclaimer below.